Skip to main content

Table 4 Overall concordance (%) of susceptibility category agreement for all EQA distributions and methods 2007–2011 and 2012–2015 (no EQA in 2013)

From: Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data

  2007–2011 2012–2015 (no EQA in 2013)a
  All methods (n = 131)b Etest (n = 72)c Agar dilution (n = 26) All methods (n = 66)b Etest (n = 52)c Agar dilution (n = 11)
Azithromycin 88 85 97 83 80 92
Cefiximed 95 93 99 91 91 91
Ceftriaxone 98 97 98 96 97 96
Ciprofloxacin 95 96 97 96 96 96
Spectinomycin 99 99 99 99 99 100
  1. a2016 results not included as only two laboratories performed agar dilution in 2016 so concordance was not calculated
  2. bIncludes disk diffusion results
  3. cSome countries have also used other MIC gradient strip tests
  4. dNot tested prior to 2010